Last Price Today's Change   Day's Range   Trading Volume
1.84   +0.02 (1.10%)  1.80 - 1.86  274,800
Trade this stock and win a FREE I3investor T-shirt after 5 trades. Find out more.


Market Cap: 1,247 Million
NOSH: 678 Million
Avg Volume (4 weeks):1,042,915
4 Weeks Range:1.78 - 2.17
4 Weeks Price Volatility (%):
52 Weeks Range:0.315 - 2.38
52 Weeks Price Volatility (%):
Average Price Target: 2.68
Price Target Upside/Downside: +0.84

Financial Highlight

Latest Quarter | Ann. Date 30-Sep-2020 [#3]  |  30-Nov-2020
Next QR | Est. Ann. Date: 31-Dec-2020  |  27-Feb-2021
T4Q P/E | EY: 63.08  |  1.59%
T4Q DY | Payout %: 0.80%  |  50.52%
T4Q NAPS | P/NAPS: 0.3338  |  5.51
T4Q NP Margin | ROE: 16.14%  |  8.74%


Date Subject
16-Feb-2021 Potentially Super Growth in 2021
07-Jan-2021 Mplus Market Pulse - 7 Jan 2021
06-Jan-2021 Sector And Sub-Sector Update : Supercomnet Technologies Berhad
18-Dec-2020 Technical View- SCOMNET (0001)
27-Nov-2020 Daily technical highlights – (ARBB, SCOMNET)
07-Sep-2020 Supercomnet Technologies - Supercharged Growth Continues
17-Aug-2020 Supercomnet Technologies - Supercharged Growth
17-Aug-2020 The Research Hive - Supercomnet Technologies Bhd (SCOMNET, 0001)
30-Jul-2020 神通网络试叩RM1.70/敏源
13-Jul-2020 PublicInvest Research Headlines - 13 Jul 2020
01-Jul-2020 SCOMNET - No worries, growth is intact! [$$bill]
27-Jun-2020 [转贴] [Facebook live video:浅谈Supercomnet Technologies bhd (Scomnet)] - James的股票投资James Share Investing
23-Jun-2020 Mplus Market Pulse - 23 Jun 2020
18-Jun-2020 热门股:神通网络上挑RM1.63
27-May-2020 M+ Online Technical Focus - 27 May 2020
19-May-2020 Trading Stocks- Supercomnet Technologies
12-May-2020 Trading Stocks - Supercomnet Technologies
23-Apr-2020 Trading Stocks - Supercomnet Technologies
14-Apr-2020 Trading Stocks (mid-day) - Supercomnet Technologies

Business Background

Supercomnet Technologies Bhd is principally involved in the manufacturing of Polyvinyl chloride (PVC) compound and cables and wires for electronic devices and data control switches. The firm’s product portfolio comprises automobile plug-in cables, copper and jumper wires, cords and cord sets, LAN cable assemblies, and a full range of computer data cables. The company’s operations are located in Malaysia.
Analyze this stock with MQ Trader system

  7 people like this.
Plantermen Business diversified and moved into medical healthcare related segments
07/01/2021 7:49 PM
Newbie318 Supercomnet Technologies (SCT MK) 
Staging For A Stronger Comeback 
3Q20 was an uneventful quarter dragged by forex losses, cost overrun and higher 
raw material cost for a new project start-up. That said, we understand these were just 
temporary setbacks which should not recur after the improvement in learning curve. 
Scomnet is staging for a stronger comeback,backed by strong orderbook visibility 
from its broad spectrum of key clients. Maintain BUY with target price of RM2.40. 
 A temporary blip. Supercomnet Technologies (Scomnet) recorded a dismal 3Q20 core 
net profit of RM5.5m (+3.5% qoq, +19.6 yoy), bringing 9M20 core net profit to Rm13.8m 
which only made up 51% of our full-year estimate. Nevertheless, 3Q20 revenue grew 7.8% 
yoy to RM37.8m, backed by stronger sales from both the medical and automobile 
 Bottom-line shortfall and margin downtick on exceptional outflows. Despite stronger 
revenue in the quarter, we noticed a plunge in net margin that impacted the bottom-line 
numbers. On a yoy basis, the slight decline in net margin (-1.1% yoy) was mainly due to 
labour and raw material cost overrun, driven by one of its key medical clients’ urgent 
demand surge for its endoscope cable. The rejection rate of this product spiked during the 
quarter, causing higher wastage of raw materials as well as overtime shifts to fulfil the 
overwhelming demand. All that being said, we understand that all these are non-recurring 
items as management has taken the necessary steps to achieve better efficiency with cost 
normalisation expected from 4Q20 onwards. 
 More clarity on SMP’s robust orderbook guidance... Our recent channel check with 
management revealed that orderbook volume for Scomnet’s medical segment, 
Supercomal Medical Products (SMP), remains strong, with orderbook visibility until 2Q21 
and 1Q22 for key clients – customer E and customer A respectively. Note that both 
customers made up about 90% of SMP’s revenue in 2019. 
 …but slight disruption from COVID-19 impact. Due to the COVID-19 disruption, there 
are some reduction in orders volume from its customer M. Vis-à-vis the decent sales 
projection from this customer which could boost its earnings by 25% from 3Q20 onwards, 
the mass production has been delayed on COVID-19 disruption. Nevertheless, the 
shortfall of revenue contribution from this customer was partially offset by stronger demand 
from customer A and customer E.

07/12/2020 6:25 PM

bigearl  Multi-pronged catalysts to sustain supercharged growth beyond 2021. We believe 
Scomnet will emerge as one of the most prominent global healthcare proxies in Malaysia 
and poised to deliver explosive earnings in FY21. This will be mainly driven by: a) resilient 
earnings visibility from its strong medical orderbooks on hand; b) incremental revenue from 
new medical products (D’Clot Catheter, Colonoscopy GI and Gastroscopy GI which will begin 
mass production in 1Q21; customer M’s D’Clot and new clients’ blood clotting product); c) 
near-term capacity expansion to fulfil explosive demand for medical segment’s products; d) 
significant contribution from new automobile client – customer P from 3Q21 onwards; and e) 
transfer to healthcare sector and mainboard listing which could catalyse a potential valuation 
 Maintain BUY with a target price of RM2.40. Post meeting, we have trimmed our 2020- 
21 revenue forecasts by 12% and 10% respectively to reflect lower contributions from 
Mermaid Medical and PSA on the slower orderbook projections. We are also assuming a 
full conversion of existing warrants into our valuations, factoring in share base of 857.3m 
shares and theoretical cash increment of RM140m. In terms of valuation (refer RHS 
valuation table), we have pegged our target price to 35x 2021F PE, its 3-year mean and at 
a discount to Bursa Malaysia Healthcare Index of 43x. 
 Medical segment: SMP will see its full potential in FY21. SMP’s growth will be fuelled 
by several new products which are poised for com
07/01/2021 8:00 PM
Newbie318 on from 2021 onwards. 
a) For customer A, the spotlight will be on its Colonoscopy GI, Gastrocopy GI and 
Duodenoscopy GI which is expected to contribute about 15-20% of incremental group 
revenue from 2021 onwards. The overwhelming demand for its endoscopy cables, 
which has seen a tremendous sales leap of several folds compared to pre-MCO 
levels, will also significantly enhance earnings. 
b) For customer E, SMP will continue to benefit from the expansion of medical 
orderbook with organic yoy growth of at least 10-16% for its existing products, while 
there are also about seven projects with customer E on hand. 
c) For customer M, the mass production of its D’Clot HD Catheter has been pushed 
back due to the delays in product training processes amid COVID-19 disruptions. 
That said, this is just a temporary setback and production should be able to start 
immediately once the doctors are able to conduct physical training and complete the 
production requirements. 
d) We also understand that SMP has secured a new client with a prominent new blood 
clotting product for dialysis. While Scomnet recently presented the product to FDA in 
Los Angeles, the approval results should be announced in Feb/Mar 21. Notably, the 
US Navy Force has signed an agreement to receive supply of this blood clotting 
product. We believe this product can contribute positively to SMP’s earnings as early 
as 2Q21 next year immediately after FDA approval, given that SMP has already 
allocated the facilities and equipment required for commercial production. 
 Automobile segment: Growth trajectory from customer P. The emergence of 
Supercomal Advanced Cables’ (SAC) latest key customer P will enhance the growth of 
Scomnet’s automobile segment. The agreement from this customer, which allows SAC to 
supply wire harnessing and fuel tanks (higher margin), is expected to contribute about 20- 
30% incremental revenue to SAC’s current revenue base in 2021, with subsequent years 
to see higher revenue contributions. 2021’s earnings growth will be backed by new 
revenue streams from this customer. We also understand that customer P has recently 
put in another RM6.6m capex into SAC to purchase wire harness and fuel tank 
production equipment.

07/12/2020 6:25 PM
07/01/2021 8:02 PM
Plantermen Good article on supercomnet medical related business.
08/01/2021 7:12 AM
jun1920 warrant fly but mother stagnant...
08/01/2021 1:28 PM
Toplove888 Still steady Abit boring no movement this few weeks... price still vry stable need to put more gas to 2.00 above
20/01/2021 6:29 PM
VTrade Shooting Star to 1.90 yesterday ??
21/01/2021 11:01 AM
BobLimm New 4 storey building coming up, growing big!
21/01/2021 3:56 PM
Newbie318 For medium and long term investors,scomnet is very good to hold.
23/01/2021 12:28 PM
Newbie318 https://www.klsescreener.com/v2/news/view/773081
24/01/2021 11:19 AM
VTrade Is good to hold if break above rm2
24/01/2021 5:48 PM
VTrade News say pick 2021 then must fast fast go buy ya.....
27/01/2021 11:07 AM
VTrade 268 very very soon.... mayb... gogo...
27/01/2021 11:10 AM
nicholas9950 what happened here?
29/01/2021 4:42 PM
t_nike2002 https://simplywall.st/stocks/my/capital-goods/klse-scomnet/supercomnet-technologies-berhad-shares/news/what-can-the-trends-at-supercomnet-technologies-berhad-klses
29/01/2021 8:10 PM
t_nike2002 Based On Simplywall analysis (27/1/21)

The trends we've noticed at Supercomnet Technologies Berhad are quite reassuring. The data shows that returns on capital have increased substantially over the last five years to 14%. The amount of capital employed has increased too, by 483%. This can indicate that there's plenty of opportunities to invest capital internally and at ever higher rates, a combination that's common among multi-baggers.

In Conclusion...

In summary, it's great to see that Supercomnet Technologies Berhad can compound returns by consistently reinvesting capital at increasing rates of return, because these are some of the key ingredients of those highly sought after multi-baggers. And with the stock having performed exceptionally well over the last five years, these patterns are being accounted for by investors.
29/01/2021 8:13 PM
Newbie318 Bravo!!!!scomnet...
2021 stock pick.
03/02/2021 7:14 PM
Newbie318 Bravo!!!!!!!!! Scomnet.
Stock pick by many lnvestment bank
for 2021.
04/02/2021 10:40 AM
Newbie318 Don't miss this tgv train.
Its going faster and faster.
04/02/2021 10:44 AM
genghis steady la.after 2 months downtrend.today up
04/02/2021 4:35 PM
donki423423 close high today,wonder any good news soon
04/02/2021 5:01 PM
Jonathan Keung Qtr result coming
04/02/2021 7:21 PM
SIQ555 Was informed Qr strong and progressing soundly, especially with several FDA approvals in hand.
04/02/2021 8:54 PM
VTrade Any Tp ?
04/02/2021 9:05 PM
Plantermen This supercomnet is not push and push counter. Slow moving but solid growth prospect
08/02/2021 8:44 AM
INVEST_AA Good opportunity to collect.... Confident with this stock...
08/02/2021 1:41 PM
INVEST_AA Next Qtr result is expected to be Niceeeee......
08/02/2021 2:03 PM
donki423423 when is the qtr result ?
08/02/2021 2:41 PM
INVEST_AA expected around end Feb - early Mar
08/02/2021 3:03 PM
gohfredd QR results deadline is 28/02/2021
08/02/2021 11:12 PM
VTrade New sop is out
09/02/2021 3:16 PM
VTrade 3days 泡泡游 and wear glove plus valentine
09/02/2021 6:46 PM
oxfordtrader Watching this counter since they were 70cents. A very well managed and good FA company to keep.
13/02/2021 10:15 PM
VTrade Bull year, congrat to those earning ...... huat ar....
15/02/2021 6:28 PM
Mr.Sm Invest123 Very fundamental & mainly medical device for ICUs.
15/02/2021 11:28 PM
Sipekhuat https://klse.i3investor.com/blogs/THP/2021-02-16-story-h1541108475-Potentially_Super_Growth_in_2021.jsp
16/02/2021 12:55 AM
Jonathan Keung Good insight on supercom
16/02/2021 1:14 PM
VSLSB I don't agree with the analysis. The articles does not explain fully what will increase profit by another 14 mil as stated. Based on current margins made the company, you must at least record 50 mil in revenue which I feel is highly unlikely judging by their current performance.

The author merely rehashed research reports by UOB and Rakuten and using a lot of "ifs", "possibly" etc.
18/02/2021 8:19 PM
bearcomebullgone ini kompany not bad .. ada mixture of medical + barangan tech... hahahah tp ... kenapa ye dia suka sangat tu medical device???? skrg 5g .. buat la tu cable modem tu banyak sikit hahahah
19/02/2021 9:43 PM
heyy08 will it up to rm2.50 this month?
22/02/2021 9:58 AM
jinova546 Lolzzz sells on news....
22/02/2021 11:43 AM
heyy08 u means will keep drop??
will not increase aldy?this month and next month
23/02/2021 10:50 AM
heyy08 anyone buy at rm2+ and still holding?
23/02/2021 5:22 PM
johotin88 I bought 1.97. Will cut loss if it goes below 1.75. Now only a good QR can save it from continue going down.
24/02/2021 1:17 PM
jinova546 I brought rm 2.....dunno wanna top-up or not. Hopefully, no need and up to 2.30 - 2.50
24/02/2021 6:04 PM
heyy08 when will the QR out?
24/02/2021 7:12 PM
BigPortfolio report out this evening. i believe is a good result.
25/02/2021 2:41 PM
mf Dow Jones 31,402.01 -559.85 1.75%
Nasdaq 13,119.43 -478.535 3.52%
26/02/2021 8:39 AM
donki423423 Is the report out?
01/03/2021 12:25 PM
BigPortfolio no report and they didnt inform when to release.
01/03/2021 2:20 PM

I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View Trading Signals and run Live Backtest
MQ Affiliate
Earn rewards with MQ Affiliate Program

428  627  572 

Top 10 Active Counters
 GFM-WC 0.20+0.125 
 GFM 0.405+0.20 
 ARMADA 0.425+0.03 
 ITRONIC 0.665+0.185 
 DNEX-WD 0.365-0.01 
 ANZO 0.08-0.015 
 KOMARK-WC 0.10-0.005 
 AAX 0.095+0.01 
 MTRONIC 0.07-0.01 
 JADI 0.135+0.025 


1. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!